The ATLANTIS Randomized Trial: Apixaban Versus Standard of Care After TAVI
Insight on the role of oral anticoagulation as default antithrombotic strategy after transcatheter aortic valve implantation.
By Antonio Greco, MD, and Davide Capodanno, MD, PhD
